News
Press Release | May 28, 2024
Affini-T Therapeutics Announces First Patient Dosed in KRAS G12V Phase 1 Program and Presentation of Trial-in-Progress Poster at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Press Release | April 2, 2024
Freenome Announces Topline Results for PREEMPT CRC® to Validate the First Version of its Blood-Based Test for the Early Detection of Colorectal Cancer
News | March 25, 2024
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
News | February 21, 2024
Q32 Bio Announces Publication of Preclinical Data in Molecular Therapy Demonstrating the Therapeutic Potential of Tissue-Targeted Complement Inhibitor ADX-097 for Complement-Mediated Diseases
Press Release | February 15, 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Press Release | February 4, 2024
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
1
2